Mean number of DNA breakpoints: illuminating sperm DNA integrity and in vitro fertilization outcomes
Wenjing Zhou, Jianeng Zhang, Zhaojun Cheng, Chong Wang, Ying Feng
Abstract
Objective To verify the capacity of the mean number of DNA breakpoints (MDB) for evaluating sperm integrity and its relationship with in vitro fertilization (IVF) outcomes. Design Retrospective cohort study. Setting Reproductive center in a tertiary hospital. Patient(s) All men whose female partners underwent IVF from March to October 2022 in the reproductive center. Intervention(s) The MDB and DNA fragmentation index (DFI) were used to assess sperm DNA integrity. The patients were stratified into two groups according to MDB and DFI cutoffs: sperm DNA-normal and sperm DNA-impaired. Main Outcome Measures Semen parameters: concentration, progressive motility (PR), MDB, and the DFI; IVF outcome measures: two pronuclei (2-PN), fertilization rate, fertilization cleavage rate, high-quality embryo rate, biochemical pregnancy rate, clinical pregnancy rate, and implantation rate. Results Sperm MDB had a higher negative correlation with PR compared with the DFI (r = −0.43; r=−0.37, respectively). Sperm MDB did not have a statistical correlation with sperm concentration, whereas the DFI correlated significantly with concentration (r = −0.17; r=−0.27, respectively). Logistic regression analysis controlling for age and semen concentration demonstrated that an increase in MDB increased the risk of asthenospermia (odds ratio=1.018, 95% confidence interval [CI] 1.003–1.034). An increasing DFI also increased the risk of asthenospermia (odds ratio=1.044, 95% CI 1.002–1.087). The MDB showed a stronger clinical relevance with sperm PR than the DFI, as indicated using the area under the curve values (0.754, 95% CI 0.649–0.859 vs. 0.691, 95% CI 0.556–0.825). A threshold of the MDB >0.37 nM was calculated to define sperm DNA-impaired. Comparison of IVF results showed that the high-quality embryo rate (χ 2 = 13.00) was significantly lower in the DNA-impaired group than in the DNA-normal group stratified using the MDB, although there were no significant differences in IVF outcomes in DFI-stratified groups. Conclusion The MDB has been verified to correlate closely with semen PR and may serve as a predictive parameter for IVF outcomes. Rigorous prospective studies are required to explore MDB performance and to further validate and reinforce the potential application of MDB as a parameter for male infertility.